>F7S]AI7|WW'$N[P^W2H^C2QZ),ZZ5D4}A-G>-Z;?!]&|8D
SYSTEM PROCESSING...
>F7S]AI7|WW'$N[P^W2H^C2QZ),ZZ5D4}A-G>-Z;?!]&|8D
SYSTEM PROCESSING...
Posted: 2025-08-02 00:59:36 UTC
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
Status
Last Updated
2025-08-02 00:59:59 UTC
Verified By
Rollup News
The FDA has rejected Regeneron's blood cancer treatment, odronextamab, for the second time due to issues at the manufacturing plant.
FDA rejection of odronextamab
Manufacturing issues at Regeneron's Indiana factory
Delay in treatment for relapsed follicular lymphoma
Manufacturing problems
FDA regulatory hurdles
Delay in patient access to treatment